Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000912057-02-033732
Filing Date
2002-08-28
Accepted
2002-08-28 11:06:24
Documents
1
Period of Report
2002-09-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2088186zdef14a.txt DEF 14A 171431
  Complete submission text file 0000912057-02-033732.txt   172910
Mailing Address 4611 UNIVERSITY DRIVE DURHAM NC 27707
Business Address 4611 UNIVERSITY DRIVE DURHAM NC 27707 9194935980
TRIANGLE PHARMACEUTICALS INC (Filer) CIK: 0001022622 (see all company filings)

EIN.: 561930728 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-21589 | Film No.: 02750472
SIC: 2834 Pharmaceutical Preparations